Source: European Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: INFLAMAÇÃO, NEUTRÓFILOS, INTERLEUCINA 1
ABNT
SANTIN, José Roberto et al. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor. European Journal of Pharmaceutical Sciences, v. 48, n. 4-5, p. 689-697, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2012.12.029. Acesso em: 23 abr. 2024.APA
Santin, J. R., Uchôa, F. de T., Lima, M. do C. A., Rabello, M. M., Machado, I. D., Hernandes, M. Z., et al. (2013). Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor. European Journal of Pharmaceutical Sciences, 48( 4-5), 689-697. doi:10.1016/j.ejps.2012.12.029NLM
Santin JR, Uchôa F de T, Lima M do CA, Rabello MM, Machado ID, Hernandes MZ, Amato AA, Milton FA, Webb P, Neves F de AR, Galdino SL, Pitta I da R, Farsky SHP. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor [Internet]. European Journal of Pharmaceutical Sciences. 2013 ; 48( 4-5): 689-697.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.ejps.2012.12.029Vancouver
Santin JR, Uchôa F de T, Lima M do CA, Rabello MM, Machado ID, Hernandes MZ, Amato AA, Milton FA, Webb P, Neves F de AR, Galdino SL, Pitta I da R, Farsky SHP. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor [Internet]. European Journal of Pharmaceutical Sciences. 2013 ; 48( 4-5): 689-697.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.ejps.2012.12.029